Market Place
Sourcing Support
Gossamer Bio`s DP2 inhibitor GB001 fails 2 midphase trials
14 Oct 2020 //
FIERCE PHARMA
Novartis dumps asthma program after another set of phase 3 flops
16 Dec 2019 //
FIERCE BIOTECH
Novartis` asthma drug fails in phase 3
22 Oct 2019 //
FIERCE BIOTECH
Novartis CEO Vas Narasimhan lines up his late-stage blockbuster contenders
06 Nov 2018 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.